あすか製薬ホールディングス(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4886/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2021/08/20 | 日証協 | 54,500株 | +3.08% | 18,817株 | -53.2% | 260,923株 | -5.63% | 18,035株 | +7.99% |
2021/08/13 | 日証協 | 52,874株 | +1.07% | 40,210株 | -35.47% | 276,497株 | -7.4% | 16,700株 | -50.62% |
2021/08/06 | 日証協 | 52,315株 | +23.09% | 62,315株 | +80.1% | 298,608株 | +2.75% | 33,816株 | +36.84% |
2021/07/30 | 日証協 | 42,500株 | -5.13% | 34,600株 | +63.28% | 290,607株 | -4.31% | 24,712株 | +286.12% |
2021/07/21 | 日証協 | 44,800株 | -3.03% | 21,190株 | -49.91% | 303,695株 | -0.62% | 6,400株 | -87.4% |
2021/07/16 | 日証協 | 46,200株 | +32.32% | 42,300株 | +168.32% | 305,595株 | +18.13% | 50,800株 | +84.68% |
2021/07/09 | 日証協 | 34,916株 | -9.58% | 15,765株 | -13.85% | 258,701株 | -2.19% | 27,507株 | -72.95% |
2021/07/02 | 日証協 | 38,616株 | +30.02% | 18,300株 | -17.17% | 264,488株 | +15.05% | 101,700株 | +16.49% |
2021/06/25 | 日証協 | 29,700株 | -6.01% | 22,093株 | +612.68% | 229,888株 | +1.25% | 87,300株 | +0.77% |
2021/06/18 | 日証協 | 31,600株 | -6.23% | 3,100株 | +138.46% | 227,053株 | +4.46% | 86,635株 | +4.51% |
2021/06/11 | 日証協 | 33,700株 | -4.78% | 1,300株 | -52.47% | 217,353株 | +6.15% | 82,900株 | +132.85% |
2021/06/04 | 日証協 | 35,393株 | -82.81% | 2,735株 | -99.63% | 204,753株 | -48.64% | 35,602株 | -80.18% |
2021/05/28 | 日証協 | 205,894株 | +112.93% | 748,929株 | +199.38% | 398,680株 | +34.65% | 179,600株 | +5.39% |
2021/05/21 | 日証協 | 96,694株 | +36.57% | 250,159株 | +567.09% | 296,080株 | +28.41% | 170,420株 | +64.33% |
2021/05/14 | 日証協 | 70,800株 | +31.11% | 37,500株 | +428.17% | 230,578株 | +19.48% | 103,706株 | +380.12% |
2021/05/07 | 日証協 | 54,000株 | +13.68% | 7,100株 | -47.41% | 192,981株 | +4.38% | 21,600株 | +2.37% |
2021/04/30 | 日証協 | 47,500株 | +59.93% | 13,500株 | -63.9% | 184,881株 | +3.59% | 21,100株 | +1.4% |
2021/04/23 | 日証協 | 29,700株 | +280.77% | 37,400株 | +320.22% | 178,481株 | +6.51% | 20,809株 | -6.27% |
2021/04/16 | 日証協 | 7,800株 | -64.71% | 8,900株 | -68.88% | 167,573株 | -14.36% | 22,200株 | -68.15% |
※株式分割は考慮していませんのでご注意ください。
Page Top